Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion

被引:38
作者
Grahovac, Jelena [1 ]
Wells, Alan [1 ]
机构
[1] Univ Pittsburgh, Dept Pathol, Pittsburgh VAMC, 3550 Terrace St, Pittsburgh, PA 15261 USA
关键词
amoeboid; cancer invasion; decorin; EGFR; mesenchymal; migration; tenascin C; EPIDERMAL-GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; SPARC-INDUCED MIGRATION; UNSPLICED TENASCIN-C; ACTIN STRESS FIBERS; EXTRACELLULAR-MATRIX; IN-VITRO; GENE-EXPRESSION; FOCAL ADHESIONS; PROTEOGLYCANS BIGLYCAN;
D O I
10.1038/labinvest.2013.132
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer invasion is a complex process requiring, among other events, extensive remodeling of the extracellular matrix including deposition of pro-migratory and pro-proliferative moieties. In recent years, it has been described that while invading through matrices cancer cells can change shape and adapt their migration strategies depending on the microenvironmental context. Although intracellular signaling pathways governing the mesenchymal to amoeboid migration shift and vice versa have been mostly elucidated, the extracellular signals promoting these shifts are largely unknown. In this review, we summarize findings that point to matrikines that bind specifically to the EGF receptor as matricellular molecules that enable cancer cell migrational plasticity and promote invasion.
引用
收藏
页码:31 / 40
页数:10
相关论文
共 160 条
  • [1] A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1
    Adams, JC
    Kureishy, N
    Tayor, AL
    [J]. JOURNAL OF CELL BIOLOGY, 2001, 152 (06) : 1169 - 1182
  • [2] Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through upregulation of the plasminogen/plasmin system
    Albo, D
    Berger, DH
    Wang, TN
    Hu, XL
    Rothman, V
    Tuszynski, GP
    [J]. SURGERY, 1997, 122 (02) : 493 - 499
  • [3] Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
    Albo, D
    Rothman, VL
    Roberts, DD
    Tuszynski, GP
    [J]. BRITISH JOURNAL OF CANCER, 2000, 83 (03) : 298 - 306
  • [4] Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer
    Albo, D
    Shinohara, T
    Tuszynski, GP
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 108 (01) : 51 - 60
  • [5] THROMBOSPONDIN (TSP) AND TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA) PROMOTE HUMAN A549 LUNG-CARCINOMA CELL PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (PAL-1) PRODUCTION AND STIMULATE TUMOR-CELL ATTACHMENT IN-VITRO
    ALBO, D
    ARNOLETTI, JP
    CASTIGLIONI, A
    GRANICK, MS
    SOLOMON, MP
    ROTHMAN, VL
    TUSZYNSKI, GP
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 203 (02) : 857 - 865
  • [6] Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
    Anderson, Alexander R. A.
    Weaver, Alissa M.
    Cummings, Peter T.
    Quaranta, Vito
    [J]. CELL, 2006, 127 (05) : 905 - 915
  • [7] Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells
    Angelucci, A
    Festuccia, C
    Gravina, GL
    Muzi, P
    Bonghi, L
    Vicentini, C
    Bologna, M
    [J]. PROSTATE, 2004, 59 (02) : 157 - 166
  • [8] SPARC: a matricellular regulator of tumorigenesis
    Arnold, Shanna A.
    Brekken, Rolf A.
    [J]. JOURNAL OF CELL COMMUNICATION AND SIGNALING, 2009, 3 (3-4) : 255 - 273
  • [9] ARNOLETTI JP, 1995, CANCER, V76, P998, DOI 10.1002/1097-0142(19950915)76:6<998::AID-CNCR2820760613>3.0.CO
  • [10] 2-0